NAV19/09/2024 Chg.+22.3499 Type de rendement Focus sur l'investissement Société de fonds
3,098.3899USD +0.73% reinvestment Equity Worldwide Candriam 

Stratégie d'investissement

Equities of companies in the field of oncology (cancer research, diagnosis, treatment, etc.) whose registered offices and/or principal activities are throughout the world. The fund seeks to achieve capital growth by investing in the principal assets traded and to outperform the benchmark while also generating a positive social impact over the long term, by selecting companies that address certain societal challenges and mobilise resources in the fight against cancer. The management team makes discretionary investment choices based on economic/financial analyses, but also on the basis of Candriam's internal analysis of environmental, social and governance (ESG) criteria.
 

Objectif d'investissement

Equities of companies in the field of oncology (cancer research, diagnosis, treatment, etc.) whose registered offices and/or principal activities are throughout the world.
 

Opérations

Type de rendement: reinvestment
Fonds Catégorie: Equity
Région de placement: Worldwide
Branche: Sector Health / Pharma
Benchmark: MSCI World (Net Return)
Début de l'exercice: 01/01
Dernière distribution: -
Banque dépositaire: CACEIS Bank, Luxembourg Branch
Domicile: Luxembourg
Permission de distribution: Austria, Germany, Switzerland, Czech Republic
Gestionnaire du fonds: Rudi Van Den Eynde, Linden Thomson
Actif net: 1.89 Mrd.  USD
Date de lancement: 14/11/2018
Focus de l'investissement: -

Conditions

Surtaxe d'émission: 0.00%
Frais d'administration max.: 0.80%
Investissement minimum: 0.00 USD
Deposit fees: -
Frais de rachat: 0.00%
Prospectus simplifié: Télécharger (Version imprimée)
 

Société de fonds

Société de fonds: Candriam
Adresse: 19-21 route d'Arlon, 8009, Strassen
Pays: Luxembourg
Internet: www.candriam.com
 

Actifs

Stocks
 
96.09%
Cash
 
3.91%

Pays

United States of America
 
53.00%
Switzerland
 
12.20%
Germany
 
7.97%
United Kingdom
 
6.70%
Denmark
 
6.31%
Japan
 
4.46%
Cash
 
3.91%
Ireland
 
1.90%
Cayman Islands
 
1.86%
Netherlands
 
1.32%
China
 
0.37%

Branches

Pharma/Biotechnology
 
69.50%
Healthcare services
 
14.66%
Healthcare appliances
 
11.93%
Cash
 
3.91%